Accelerate Neurology/Psychiatry Trial Success with Expert Guidance
Learn how our neuroscience team partner with sponsors across multiple therapeutic areas to...
Beyond Detection: How ctDNA Could Optimize Treatment Selection
The promise of circulating tumor DNA (ctDNA) extends far beyond simply detecting cancer; it also...
Targeted Indication Selection Using Simon 2-Stage Design
Learn how Veristat’s biostatistics and strategic consulting teams were able to work with a...
Monthly FDA Guidance and Regulatory News Review - September 2025
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
What RAPS Convergence 2025 Means for Sponsors Preparing Global Submissions
It was wonderful to connect with so many of our peers at RAPS Convergence 2025 in Pittsburgh. As...
Accelerating Patient-Centric Trials: A Sponsor Checklist for Science-Based Planning
Learn how our patient-centric approach helps sponsors streamline development and reduce trial...
Why Regulatory Publishing Expertise is Essential for Neurology Clinical Trials
Developing treatments for neurological, psychiatric, or CNS disorders means navigating complex...
Advancing Dose Escalation Strategies with Bayesian Modeling
Learn how our biostatistics and strategic consulting teams collaborated with our biotechnology...
3 Reasons Why You Need to Consider a CRO That Excels in Oncology Regulatory Publishing
In oncology drug development, every day counts. Patients are waiting, trials are complex, and the...
Advancing Oncology Innovation with Adaptive Trial Designs
Learn how our strategic and regulatory team was able to work with a biopharmaceutical sponsor to...